Ferritin-Based Targeted Delivery of Arsenic to Diverse Leukemia Types Confers Strong Anti-Leukemia Therapeutic Effects

Scientists designed a ferritin-based As nanomedicine, As@Fn, that bound to leukemia cells with very high affinity, and efficiently delivered cytotoxic AsIII into a large diversity of leukemia cell lines and patient cells.